LINAGLIPTIN TAISHO ® (linagliptin) TAISHO HK Reg. No. HK-68588 (26 Feb, 2025) Composition: 2 • Linagliptin is available as 5 mg oral tablets Indication: 2 • Linagliptin is used with diet and exercise to help lower blood sugar levels in...

RYZODEG ® (insulin aspart, insulin degludec) NOVO NORDISK HK Reg. No. HK-68663 (28 Apr, 2025) Composition: 4 • Ryzodeg 100 units/mL FlexTouch solution for injection in pre-filled pen • 1 mL solution contains 100 units insulin degludec/...

Nilemdo ® (bempedoic acid) Daiichi Sankyo Composition: • Available as film-coated tablet containing 180 mg of bempedoic acid Indication: • As an adjunct to diet and maximally tolerated statin therapy for the treatment of adults wi...

Euthyrox ® (levothyroxine sodium) Merck Composition: • Available as tablet containing 25, 50 or 100 µg of levothyroxine sodium Indication: • Euthyrox® 25-200 µg is indicated for the substitution therapy in hypothyroid...

Nustendi ® (bempedoic acid) Daiichi Sankyo Composition: • Available as film-coated tablet containing 180 mg of bempedoic acid and 10 mg of ezetimibe Indication: • As an adjunct to diet and maximally tolerated statin therapy for th...

Exkivity® ( mobocertinib ) 1-3 Takeda Mobocertinib is a kinase inhibitor of the epidermal growth factor receptor (EGFR) that selectively inhibits and irreversibly binds to EGFR exon 20 insertion mutations at lower concentrations than Wild type (...

Kerendia ® ( Finerenone ) 4 Bayer Finerenone is a nonsteroidal mineralocorticoid receptor (MR) antagonist Compositio n : Available as 10mg and 20mg oral tablets Indications : Newly indicated for delaying progressive decline of kidney function ...